IP Verse

Competitive analysis in Infection Drugs industry

Top companies filing patent oppositions

Company
FRESENIUS KABI DEUTSCHLAND GMBH
Total Oppositions
11
Company
N.V. NUTRICIA
Total Oppositions
11
Company
STRAWMAN LIMITED
Total Oppositions
10
Company
AERA A/S
Total Oppositions
10
Company
GENERICS (U.K.) LIMITED
Total Oppositions
8
Company
KONIG SZYNKA TILMANN VON RENESSE
Total Oppositions
8
Company
SANDOZ AG
Total Oppositions
7
Company
BOEHRINGER INGELHEIM VETMEDICA GMBH
Total Oppositions
7
Company
SANOFI
Total Oppositions
7
Company
PFIZER INC.
Total Oppositions
6

Top companies facing patent oppositions

Company
MERCK SHARP & DOHME CORP.
Total Oppositions
26
Company
MERCK SHARP & DOHME LLC
Total Oppositions
26
Company
INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Total Oppositions
16
Company
GLAXOSMITHKLINE BIOLOGICALS SA
Total Oppositions
14
Company
GLAXOSMITHKLINE BIOLOGICALS S.A.
Total Oppositions
14
Company
EMORY UNIVERSITY
Total Oppositions
12
Company
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Total Oppositions
12
Company
DANA-FARBER CANCER INSTITUTE, INC.
Total Oppositions
12
Company
NESTEC S.A.
Total Oppositions
12
Company
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Total Oppositions
12

Latest patents granted in the Infection Drugs industry

Patent:
EP2819699
Grant Date:
Oct 16, 2024
Title:
Controlled Release Compositions And Their Methods Of Use
Applicant:
BAYER NEW ZEALAND LIMITED
Patent:
EP3076983
Grant Date:
Aug 14, 2024
Title:
Ionic Aqueous Compositions
Applicant:
GEROLYMATOS INTERNATIONAL S.A.
Patent:
EP2836223
Grant Date:
Mar 6, 2024
Title:
Probiotic Bacteria
Applicant:
SKINBIOTHERAPEUTICS PLC
Patent:
EP2658399
Grant Date:
Feb 28, 2024
Title:
Nutritional Compositions Comprising Human Milk Oligosaccharides And Nucleotides And Uses Thereof For Treating And/Or Preventing Enteric Viral Infection
Applicant:
ABBOTT LABORATORIES
Patent:
EP3137060
Grant Date:
Dec 20, 2023
Title:
Extended Release Suspension Compositions
Applicant:
SUN PHARMACEUTICAL INDUSTRIES LTD
Patent:
EP2679681
Grant Date:
Nov 15, 2023
Title:
Fc Riib-Specific Fc Antibody
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Patent:
EP3583947
Grant Date:
Oct 11, 2023
Title:
Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates Thereof
Applicant:
PFIZER INC.
Patent:
EP2504353
Grant Date:
Sep 13, 2023
Title:
Lipopeptide Compositions And Related Methods
Applicant:
CUBIST PHARMACEUTICALS, INC.
Patent:
EP3269717
Grant Date:
Aug 9, 2023
Title:
Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104
Applicant:
PFIZER IRELAND PHARMACEUTICALS
Patent:
EP3054784
Grant Date:
Aug 2, 2023
Title:
Composition And Fodder Comprising Medium Chain Fatty Acids
Applicant:
NUTRITION SCIENCES N.V.

Top patents facing oppositions in Infection Drugs industry

Patent
EP2397155
Grant Date
Dec 13, 2017
Title
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)Pathway
Applicant
THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Oppositions
54
Patent
EP3391890
Grant Date
Aug 25, 2021
Title
Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-Cyclodextrin
Applicant
MERCK SHARP & DOHME CORP.
Oppositions
40
Patent
EP2913327
Grant Date
Jun 7, 2023
Title
Methylene Blue And Its Medical Use
Applicant
PROVEPHARM LIFE SOLUTIONS
Oppositions
30
Patent
EP4008357
Grant Date
Dec 28, 2022
Title
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant
GLAXOSMITHKLINE BIOLOGICALS SA
Oppositions
24
Patent
EP3153526
Grant Date
Sep 23, 2020
Title
Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity
Applicant
INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Oppositions
16
Patent
EP2689010
Grant Date
Nov 18, 2020
Title
Method And Compositions For Cellular Immunotherapy
Applicant
FRED HUTCHINSON CANCER RESEARCH CENTER
Oppositions
12
Patent
EP3597216
Grant Date
Aug 24, 2022
Title
Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof
Applicant
E. R. SQUIBB & SONS, L.L.C.
Oppositions
10
Patent
EP2133365
Grant Date
May 17, 2017
Title
Compositions And Methods For The Treatment Of Infections And Tumors
Applicant
DANA-FARBER CANCER INSTITUTE, INC.
Oppositions
9
Patent
EP2836223
Grant Date
Mar 6, 2024
Title
Probiotic Bacteria
Applicant
SKINBIOTHERAPEUTICS PLC
Oppositions
9
Patent
EP2691112
Grant Date
May 23, 2018
Title
Stable Formulations Of Antibodies To Human Programmed Death Receptor Pd-1 And Related Treatments
Applicant
MERCK SHARP & DOHME CORP.
Oppositions
8

Need more information?

Feel free to send us a message here and we will get back to you